SCHEMBL9108550

SCHEMBL9108550

Cc1cccc(COc2cc(C)n(-c3ccnc(-c4ccnc(C(C)(C)C)n4)c3)c(=O)c2C)c1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 3/20 0.44
MAPKAPK5 Q8IW41 1/20 0.38
MAPK14 Q16539 6/20 0.37
MAOB P27338 3/20 0.37
MAOA P21397 1/20 0.37
MRGPRX4 Q96LA9 3/20 0.35
SGMS2 Q8NHU3 1/20 0.35
PIK3CA P42336 1/20 0.33
PTGER1 P34995 1/20 0.32
ACHE P22303 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
GAA P10253 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9110573 0.93 MAPKAPK2 (0.46) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA
SCHEMBL9109760 0.92 MAPKAPK2 (0.53) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA
SCHEMBL9110251 0.91 MAPK14 (0.48) MAPKAPK2MAPKAPK5MAPK14
SCHEMBL9112232 0.91 MAPKAPK2 (0.41) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA
SCHEMBL9111055 0.91 MAPKAPK2 (0.42) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA
SCHEMBL9112896 0.87 MAPKAPK2 (0.59) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA
SCHEMBL9111855 0.86 MAPK14 (0.52) MAPKAPK2MAPKAPK5MAPK14PTGER1
SCHEMBL9112100 0.86 MAPK14 (0.37) MAPK14MAOBMAOAMRGPRX4SGMS2
SCHEMBL9109147 0.86 MAPKAPK2 (0.44) MAPKAPK2MAPKAPK5MAPK14
SCHEMBL9112295 0.85 MAPKAPK2 (0.54) MAPKAPK2MAPKAPK5MAPK14MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3469907-B1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS INC (US) 2021-03-03 EP claimed
EP-3469907-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS Aclaris Therapeutics, Inc. (US) 2019-04-17 EP claimed
US-9365546-B2 Substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES INC. (US) 2016-06-14 US claimed
US-20140171449-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS CONFLUENCE LIFE SCIENCES INC. (US) 2014-06-19 US claimed
US-20120142709-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS, INC. 2012-06-07 US claimed
EP-3469907-B1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS INC (US) 2021-03-03 EP disclosed
EP-3469907-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS Aclaris Therapeutics, Inc. (US) 2019-04-17 EP disclosed
EP-2648516-B1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS INC (US) 2018-09-05 EP disclosed
US-9365546-B2 Substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES INC. (US) 2016-06-14 US disclosed
US-9365547-B2 Substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES INC. (US) 2016-06-14 US disclosed
US-20140171449-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS CONFLUENCE LIFE SCIENCES INC. (US) 2014-06-19 US disclosed
US-20140171450-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS CONFLUENCE LIFE SCIENCES INC. (US) 2014-06-19 US disclosed
US-20120142709-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS, INC. 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171450-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS MAPK1, MAP3K1, MAP3K6 MAPKAPK2 33/4885MAPKAPK5 35/4885MAPK14 47/4885
US-20120142709-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS MAPK1, MAP3K1, MAP3K6 MAPKAPK2 33/4885MAPKAPK5 35/4885MAPK14 47/4885
US-20140171449-A1 SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS MAPK1, MAP3K1, MAP3K6 MAPKAPK2 33/4885MAPKAPK5 35/4885MAPK14 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.